Soy isoflavones (genistein, daidzein)

Soy isoflavones are plant compounds (polyphenols) that act as weak estrogens. They look structurally similar to your body's estrogen (17β-estradiol). They are concentrated in soybeans and soy foods. The two main active forms are genistein and daidzein (released by gut bacteria). Both prefer to bind estrogen receptor beta (ERβ). But they grip 100 to 1,000 times weaker than your own estrogen, so they act as tissue-selective partial on/off switches. One twist is 'equol production'. About 20 to 30% of Western adults, and 50 to 60% of Asian adults, carry gut bacteria that convert daidzein into S-equol, a stronger ERβ binder. (The main bugs are Adlercreutzia equolifaciens and Slackia isoflavoniconvertens.) That explains a lot of why people respond differently. In trials, isoflavones meaningfully cut hot-flash frequency (Luan 2025). They also slightly lower LDL cholesterol, about 5 mg/dL across 11 trials (Taku 2007). Equol producers benefit more. And a 2022 meta-analysis (Boutas et al., 18 studies) found no higher breast-cancer risk, and a hint of lower recurrence. That fits ERβ's anti-growth signal in breast tissue, which differs from the ERα-driven tumor promotion seen with pharmaceutical estrogens.

Last reviewed: June 22, 2026

This definition is educational and is not medical advice, a diagnosis, or treatment. Talk to a doctor about any health decisions. Read our full medical disclaimer